Visual Impairment in the Absence of Dystroglycan
13136 • The Journal of Neuroscience, October 21, 2009 • 29(42):13136–13146 Neurobiology of Disease Visual Impairment in the Absence of Dystroglycan Jakob S. Satz,1,2,3,4 Alisdair R. Philp,1,6 Huy Nguyen,5 Hajime Kusano,1,2,3,4 Jane Lee,1,2,3,4 Rolf Turk,1,2,3,4 Megan J. Riker,6 Jasmine Herna´ndez,6 Robert M. Weiss,4 Michael G. Anderson,2,6 Robert F. Mullins,6 Steven A. Moore,5 Edwin M. Stone,1,6 and Kevin P. Campbell1,2,3,4 1Howard Hughes Medical Institute and Departments of 2Molecular Physiology and Biophysics, 3Neurology, 4Internal Medicine, 5Pathology, and 6Ophthalmology and Visual Sciences, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242 Ocular involvement in muscular dystrophy ranges from structural defects to abnormal electroretinograms. While the mechanisms underlyingtheabnormalretinalphysiologyinpatientsarenotunderstood,itisthoughtthat␣-dystroglycanextracellularinteractionsare critical for normal visual function. Here we show that -dystroglycan anchors dystrophin and the inward rectifying K ϩ channel Kir4.1 at glial endfeet and that disruption of dystrophin and potassium channel clustering in dystroglycan mutant mice is associated with an attenuationoftheelectroretinogramb-wave.Glial-specificinactivationofdystroglycanordeletionofthecytoplasmicdomainof-dystroglycan was sufficient to attenuate the electroretinogram b-wave. Unexpectedly, deletion of the -dystroglycan cytoplasmic domain did not disrupt the laminar structure of the retina. In contrast to the role of ␣-dystroglycan extracellular interactions during early development of the CNS, -dystroglycan intracellular interactions are important for visual function but not the laminar development of the retina. Introduction and dystrobrevin (Ervasti and Campbell, 1991; Ibraghimov- Muscular dystrophies with ocular involvement are associated Beskrovnaya et al., 1992; Cohn and Campbell, 2000).
[Show full text]